##gff-version 3
##sequence-region P04062 1 536
P04062	UniProtKB	Signal peptide	1	39	.	.	.	Ontology_term=ECO:0000269;evidence=ECO:0000269|Ref.12	
P04062	UniProtKB	Chain	40	536	.	.	.	ID=PRO_0000012177;Note=Lysosomal acid glucosylceramidase	
P04062	UniProtKB	Active site	274	274	.	.	.	Note=Proton donor;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15817452;Dbxref=PMID:15817452	
P04062	UniProtKB	Active site	379	379	.	.	.	Note=Nucleophile;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15817452;Dbxref=PMID:15817452	
P04062	UniProtKB	Glycosylation	58	58	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12792654,ECO:0000269|PubMed:17139081;Dbxref=PMID:12792654,PMID:17139081	
P04062	UniProtKB	Glycosylation	98	98	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12754519,ECO:0000269|PubMed:17139081,ECO:0000269|PubMed:19159218;Dbxref=PMID:12754519,PMID:17139081,PMID:19159218	
P04062	UniProtKB	Glycosylation	185	185	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12754519,ECO:0000269|PubMed:17139081;Dbxref=PMID:12754519,PMID:17139081	
P04062	UniProtKB	Glycosylation	309	309	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12754519,ECO:0000269|PubMed:19159218;Dbxref=PMID:12754519,PMID:19159218	
P04062	UniProtKB	Glycosylation	501	501	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P04062	UniProtKB	Disulfide bond	43	55	.	.	.	Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12792654;Dbxref=PMID:12792654	
P04062	UniProtKB	Disulfide bond	57	62	.	.	.	Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12792654;Dbxref=PMID:12792654	
P04062	UniProtKB	Alternative sequence	1	161	.	.	.	ID=VSP_025216;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:8294033;Dbxref=PMID:8294033	
P04062	UniProtKB	Alternative sequence	1	87	.	.	.	ID=VSP_054655;Note=In isoform 4. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
P04062	UniProtKB	Alternative sequence	1	20	.	.	.	ID=VSP_018800;Note=In isoform Short. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:3001061,ECO:0000303|PubMed:3864160;Dbxref=PMID:3001061,PMID:3864160	
P04062	UniProtKB	Alternative sequence	103	151	.	.	.	ID=VSP_054656;Note=In isoform 5. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
P04062	UniProtKB	Alternative sequence	422	423	.	.	.	ID=VSP_025217;Note=In isoform 3. LA->PS;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:8294033;Dbxref=PMID:8294033	
P04062	UniProtKB	Alternative sequence	425	536	.	.	.	ID=VSP_025218;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:8294033;Dbxref=PMID:8294033	
P04062	UniProtKB	Natural variant	46	46	.	.	.	ID=VAR_063066;Note=In a patient with Parkinson disease. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19286695;Dbxref=dbSNP:rs142761046,PMID:19286695	
P04062	UniProtKB	Natural variant	54	54	.	.	.	ID=VAR_003255;Note=In GD. V->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8829654;Dbxref=dbSNP:rs121908302,PMID:8829654	
P04062	UniProtKB	Natural variant	55	55	.	.	.	ID=VAR_032394;Note=In GD%3B neuronopathic and perinatal lethal forms%3B loss of glucosylceramidase activity. C->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11992489,ECO:0000269|PubMed:15292921,ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs773007510,PMID:11992489,PMID:15292921,PMID:16293621	
P04062	UniProtKB	Natural variant	62	62	.	.	.	ID=VAR_081188;Note=In GD1. C->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24434810;Dbxref=PMID:24434810	
P04062	UniProtKB	Natural variant	63	63	.	.	.	ID=VAR_032395;Note=In GD1%3B very low glucosylceramidase activity. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15605411;Dbxref=PMID:15605411	
P04062	UniProtKB	Natural variant	76	76	.	.	.	ID=VAR_003256;Note=In GD. F->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9217217;Dbxref=PMID:9217217	
P04062	UniProtKB	Natural variant	80	80	.	.	.	ID=VAR_009033;Note=In GD2. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9851895;Dbxref=PMID:9851895	
P04062	UniProtKB	Natural variant	82	82	.	.	.	ID=VAR_003257;Note=In GD. T->I;Dbxref=dbSNP:rs1141811	
P04062	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_003258;Note=In GD. G->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:8829654,ECO:0000269|PubMed:9217217;Dbxref=dbSNP:rs77829017,PMID:8829654,PMID:9217217	
P04062	UniProtKB	Natural variant	87	87	.	.	.	ID=VAR_032197;Note=In GD%3B decreased glucosylceramidase activity%3B 20%25 of normal activity. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs78769774,PMID:16293621	
P04062	UniProtKB	Natural variant	87	87	.	.	.	ID=VAR_003259;Note=In GD%3B mild. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10796875,ECO:0000269|PubMed:9153297,ECO:0000269|PubMed:9217217;Dbxref=dbSNP:rs1141814,PMID:10796875,PMID:9153297,PMID:9217217	
P04062	UniProtKB	Natural variant	92	92	.	.	.	ID=VAR_032396;Note=M->T;Dbxref=dbSNP:rs1141815	
P04062	UniProtKB	Natural variant	118	118	.	.	.	ID=VAR_003260;Note=In GD%3B mild%3B decreased glucosylceramidase activity%3B 8%25 of normal activity%3B increases susceptibility to proteolytic degradation. K->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10796875,ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs121908312,PMID:10796875,PMID:16293621	
P04062	UniProtKB	Natural variant	129	129	.	.	.	ID=VAR_032397;Note=In GD. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10796875;Dbxref=PMID:10796875	
P04062	UniProtKB	Natural variant	146	146	.	.	.	ID=VAR_009034;Note=In GD%3B type 2. S->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9554454;Dbxref=dbSNP:rs758447515,PMID:9554454	
P04062	UniProtKB	Natural variant	152	152	.	.	.	ID=VAR_003261;Note=In GD. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9554746;Dbxref=PMID:9554746	
P04062	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_032398;Note=In GD. N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10796875;Dbxref=PMID:10796875	
P04062	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_032399;Note=In GD1%3B very low glucosylceramidase activity. I->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15605411;Dbxref=dbSNP:rs77834747,PMID:15605411	
P04062	UniProtKB	Natural variant	158	158	.	.	.	ID=VAR_003262;Note=In GD. I->T;Dbxref=dbSNP:rs77834747	
P04062	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_003263;Note=In GD%3B type 2%3B decreased glucosylceramidase activity%3B 13%25 of normal activity. R->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10796875,ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs79653797,PMID:10796875,PMID:16293621	
P04062	UniProtKB	Natural variant	159	159	.	.	.	ID=VAR_003264;Note=In GD%3B severe. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10796875,ECO:0000269|PubMed:15605411,ECO:0000269|PubMed:9217217;Dbxref=dbSNP:rs439898,PMID:10796875,PMID:15605411,PMID:9217217	
P04062	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_032198;Note=In GD%3B decreased glucosylceramidase activity%3B 16%25 of normal activity. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs79637617,PMID:16293621	
P04062	UniProtKB	Natural variant	161	161	.	.	.	ID=VAR_003265;Note=In GD%3B mild. P->S;Dbxref=dbSNP:rs121908299	
P04062	UniProtKB	Natural variant	162	162	.	.	.	ID=VAR_032199;Note=In GD%3B loss of glucosylceramidase activity%3B increases susceptibility to proteolytic degradation. M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs377325220,PMID:16293621	
P04062	UniProtKB	Natural variant	166	166	.	.	.	ID=VAR_032200;Note=In GD%3B decreased glucosylceramidase activity%3B 9%25 of normal activity%3B increases susceptibility to proteolytic degradation. D->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs79796061,PMID:16293621	
P04062	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_009035;Note=In GD1 and GD2%3B also found in a patient with Parkinson disease. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15605411,ECO:0000269|PubMed:19286695,ECO:0000269|PubMed:9851895;Dbxref=dbSNP:rs398123530,PMID:15605411,PMID:19286695,PMID:9851895	
P04062	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_009036;Note=In GD. R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10796875;Dbxref=dbSNP:rs80356763,PMID:10796875	
P04062	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_032400;Note=In GD. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10796875;Dbxref=dbSNP:rs78657146,PMID:10796875	
P04062	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_003266;Note=In GD. T->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10447266,ECO:0000269|PubMed:9554746;Dbxref=dbSNP:rs1441909908,PMID:10447266,PMID:9554746	
P04062	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_032401;Note=In GD. A->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11933202;Dbxref=dbSNP:rs79660787,PMID:11933202	
P04062	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_003267;Note=In GD%3B decreased glucosylceramide catabolic process. D->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15916907,ECO:0000269|PubMed:1864608;Dbxref=dbSNP:rs147138516,PMID:15916907,PMID:1864608	
P04062	UniProtKB	Natural variant	196	196	.	.	.	ID=VAR_003268;Note=In GD%3B severe%3B decreased protein abundance%3B decreased glucosylceramide catabolic process. K->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15916907,ECO:0000269|PubMed:1864608;Dbxref=dbSNP:rs121908297,PMID:15916907,PMID:1864608	
P04062	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_009037;Note=In GD. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9554454;Dbxref=dbSNP:rs80222298,PMID:9554454	
P04062	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_081189;Note=In GD1%3B decreased glucosylceramide catabolic process. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24022302;Dbxref=PMID:24022302	
P04062	UniProtKB	Natural variant	198	198	.	.	.	ID=VAR_032402;Note=In GD. P->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12204005;Dbxref=PMID:12204005	
P04062	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_032201;Note=In GD%3B decreased glucosylceramidase activity%3B 5%25 of normal activity. I->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs77933015,PMID:16293621	
P04062	UniProtKB	Natural variant	200	200	.	.	.	ID=VAR_010059;Note=In GD. I->S;Dbxref=dbSNP:rs77933015	
P04062	UniProtKB	Natural variant	201	201	.	.	.	ID=VAR_032403;Note=In GD. H->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11933202;Dbxref=dbSNP:rs76500263,PMID:11933202	
P04062	UniProtKB	Natural variant	209	209	.	.	.	ID=VAR_032404;Note=In GD. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10796875;Dbxref=dbSNP:rs398123532,PMID:10796875	
P04062	UniProtKB	Natural variant	209	209	.	.	.	ID=VAR_003269;Note=In GD. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10796875;Dbxref=dbSNP:rs749416070,PMID:10796875	
P04062	UniProtKB	Natural variant	213	213	.	.	.	ID=VAR_032202;Note=In GD%2C decreased glucosylceramidase activity%3B 12%25 of normal activity. L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs374591570,PMID:16293621	
P04062	UniProtKB	Natural variant	215	215	.	.	.	ID=VAR_003270;Note=In GD. A->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8790604;Dbxref=PMID:8790604	
P04062	UniProtKB	Natural variant	217	217	.	.	.	ID=VAR_003271;Note=In GD%3B type 2. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7627192;Dbxref=PMID:7627192	
P04062	UniProtKB	Natural variant	221	221	.	.	.	ID=VAR_032405;Note=In GD1%3B very low glucosylceramidase activity. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15605411;Dbxref=dbSNP:rs80205046,PMID:15605411	
P04062	UniProtKB	Natural variant	221	221	.	.	.	ID=VAR_003272;Note=In GD. P->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8790604;Dbxref=dbSNP:rs866075757,PMID:8790604	
P04062	UniProtKB	Natural variant	223	223	.	.	.	ID=VAR_003273;Note=In GD%3B gene conversion. W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8294033;Dbxref=dbSNP:rs61748906,PMID:8294033	
P04062	UniProtKB	Natural variant	224	224	.	.	.	ID=VAR_032203;Note=In GD%3B decreased glucosylceramidase activity%3B 4%25 of normal activity%3B increases susceptibility to proteolytic degradation. L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=PMID:16293621	
P04062	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_081190;Note=In GD2%3B decreased glucosylceramide catabolic process. N->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24022302;Dbxref=PMID:24022302	
P04062	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_003275;Note=In GD%3B gene conversion. N->K;Dbxref=dbSNP:rs381418	
P04062	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_003274;Note=In GD and GD3%3B decreased glucosylceramide catabolic process. N->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10796875,ECO:0000269|PubMed:24022302,ECO:0000269|PubMed:8829654,ECO:0000269|PubMed:9217217;Dbxref=dbSNP:rs364897,PMID:10796875,PMID:24022302,PMID:8829654,PMID:9217217	
P04062	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_010060;Note=In GD. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9061570;Dbxref=dbSNP:rs78911246,PMID:9061570	
P04062	UniProtKB	Natural variant	229	229	.	.	.	ID=VAR_009038;Note=In GD2. A->E;Dbxref=dbSNP:rs75636769	
P04062	UniProtKB	Natural variant	229	229	.	.	.	ID=VAR_032406;Note=In GD. A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10796875;Dbxref=PMID:10796875	
P04062	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_032407;Note=In GD1%3B very low glucosylceramidase activity. V->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15605411;Dbxref=dbSNP:rs381427,PMID:15605411	
P04062	UniProtKB	Natural variant	230	230	.	.	.	ID=VAR_003276;Note=In GD1%3B gene conversion. V->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10206680,ECO:0000269|PubMed:8294033;Dbxref=dbSNP:rs381427,PMID:10206680,PMID:8294033	
P04062	UniProtKB	Natural variant	232	232	.	.	.	ID=VAR_032204;Note=In GD%3B also found in a patient with Parkinson disease%3B decreased glucosylceramidase activity%3B 7%25 of normal activity. G->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16293621,ECO:0000269|PubMed:19286695;Dbxref=dbSNP:rs1376479747,PMID:16293621,PMID:19286695	
P04062	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_003277;Note=In GD%3B severe. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9153297;Dbxref=dbSNP:rs74462743,PMID:9153297	
P04062	UniProtKB	Natural variant	234	234	.	.	.	ID=VAR_009039;Note=In GD. G->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10447266;Dbxref=PMID:10447266	
P04062	UniProtKB	Natural variant	235	235	.	.	.	ID=VAR_003278;Note=In GD2%3B gene conversion. S->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10796875,ECO:0000269|PubMed:8294033;Dbxref=dbSNP:rs1064644,PMID:10796875,PMID:8294033	
P04062	UniProtKB	Natural variant	237	237	.	.	.	ID=VAR_032205;Note=In GD%3B severe%3B loss of glucosylceramidase activity%3B increases susceptibility to proteolytic degradation. K->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11933202,ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs773409311,PMID:11933202,PMID:16293621	
P04062	UniProtKB	Natural variant	241	241	.	.	.	ID=VAR_010061;Note=In GD. G->E;Dbxref=dbSNP:rs77451368	
P04062	UniProtKB	Natural variant	241	241	.	.	.	ID=VAR_003279;Note=In GD1 and GD2%3B gene conversion. G->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10360404,ECO:0000269|PubMed:10796875,ECO:0000269|PubMed:12204005,ECO:0000269|PubMed:15605411,ECO:0000269|PubMed:8294033,ECO:0000269|PubMed:8790604,ECO:0000269|PubMed:9153297;Dbxref=dbSNP:rs409652,PMID:10360404,PMID:10796875,PMID:12204005,PMID:15605411,PMID:8294033,PMID:8790604,PMID:9153297	
P04062	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_010062;Note=In GD. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10360404;Dbxref=dbSNP:rs76026102,PMID:10360404	
P04062	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_003280;Note=In GD. Y->H;Dbxref=dbSNP:rs121908300	
P04062	UniProtKB	Natural variant	252	252	.	.	.	ID=VAR_003281;Note=In GD2%3B gene conversion. F->I;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10360404,ECO:0000269|PubMed:10796875,ECO:0000269|PubMed:8294033,ECO:0000269|PubMed:9061570,ECO:0000269|PubMed:9153297,ECO:0000269|PubMed:9217217;Dbxref=dbSNP:rs381737,PMID:10360404,PMID:10796875,PMID:8294033,PMID:9061570,PMID:9153297,PMID:9217217	
P04062	UniProtKB	Natural variant	255	255	.	.	.	ID=VAR_003282;Note=In GD%3B mild. F->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:1974409;Dbxref=dbSNP:rs74500255,PMID:1974409	
P04062	UniProtKB	Natural variant	266	266	.	.	.	ID=VAR_081191;Note=In GD1. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24577513;Dbxref=PMID:24577513	
P04062	UniProtKB	Natural variant	270	270	.	.	.	ID=VAR_032408;Note=In GD. T->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12204005;Dbxref=dbSNP:rs76725886,PMID:12204005	
P04062	UniProtKB	Natural variant	274	274	.	.	.	ID=VAR_081192;Note=In GD2%3B loss of glucosylceramide catabolic process. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24022302;Dbxref=PMID:24022302	
P04062	UniProtKB	Natural variant	276	276	.	.	.	ID=VAR_003283;Note=In GD. S->P	
P04062	UniProtKB	Natural variant	284	284	.	.	.	ID=VAR_081193;Note=In GD1%3B loss of glucosylceramide catabolic process. P->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24022302;Dbxref=PMID:24022302	
P04062	UniProtKB	Natural variant	289	289	.	.	.	ID=VAR_081194;Note=In GD1. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22658918;Dbxref=dbSNP:rs878853321,PMID:22658918	
P04062	UniProtKB	Natural variant	290	290	.	.	.	ID=VAR_032409;Note=In GD%3B perinatal lethal form. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11933202;Dbxref=dbSNP:rs121908313,PMID:11933202	
P04062	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_009040;Note=In GD1 and GD2. H->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15605411;Dbxref=dbSNP:rs367968666,PMID:15605411	
P04062	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_003284;Note=In GD2%3B also found in a patient with Parkinson disease. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10796875,ECO:0000269|PubMed:19286695,ECO:0000269|PubMed:8790604;Dbxref=dbSNP:rs78973108,PMID:10796875,PMID:19286695,PMID:8790604	
P04062	UniProtKB	Natural variant	298	298	.	.	.	ID=VAR_009041;Note=In GD2%3B decreased glucosylceramidase activity%3B 4%25 of normal activity. F->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16293621,ECO:0000269|PubMed:3001061;Dbxref=PMID:16293621,PMID:3001061	
P04062	UniProtKB	Natural variant	301	301	.	.	.	ID=VAR_081195;Note=In GD1. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22658918;Dbxref=PMID:22658918	
P04062	UniProtKB	Natural variant	303	303	.	.	.	ID=VAR_032206;Note=In GD%3B decreased glucosylceramidase activity%3B 5%25 of normal activity. L->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs1296507371,PMID:16293621	
P04062	UniProtKB	Natural variant	304	304	.	.	.	ID=VAR_010063;Note=In GD. G->D;Dbxref=dbSNP:rs80116658	
P04062	UniProtKB	Natural variant	304	304	.	.	.	ID=VAR_081196;Note=In GD3%3B loss of glucosylceramide catabolic process. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24022302;Dbxref=PMID:24022302	
P04062	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_003285;Note=In GD%3B mild. P->R;Dbxref=dbSNP:rs79215220	
P04062	UniProtKB	Natural variant	310	310	.	.	.	ID=VAR_032410;Note=S->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8294033;Dbxref=dbSNP:rs1057942,PMID:8294033	
P04062	UniProtKB	Natural variant	310	310	.	.	.	ID=VAR_010064;Note=In GD%3B decreased glucosylceramidase activity%3B less than 5%25 of normal activity. S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9153297;Dbxref=dbSNP:rs74731340,PMID:9153297	
P04062	UniProtKB	Natural variant	324	324	.	.	.	ID=VAR_003286;Note=In GD1. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10796875,ECO:0000269|PubMed:15605411,ECO:0000269|PubMed:8790604;Dbxref=dbSNP:rs765633380,PMID:10796875,PMID:15605411,PMID:8790604	
P04062	UniProtKB	Natural variant	324	324	.	.	.	ID=VAR_009042;Note=In GD2. R->H;Dbxref=dbSNP:rs79696831	
P04062	UniProtKB	Natural variant	328	328	.	.	.	ID=VAR_003287;Note=In GD%3B mild. P->L;Dbxref=dbSNP:rs121908298	
P04062	UniProtKB	Natural variant	342	342	.	.	.	ID=VAR_003288;Note=In GD. K->I;Dbxref=dbSNP:rs77714449	
P04062	UniProtKB	Natural variant	343	343	.	.	.	ID=VAR_009043;Note=In GD2%3B decreased glucosylceramidase activity%3B 16%25 of normal activity%3B increases susceptibility to proteolytic degradation. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs77321207,PMID:16293621	
P04062	UniProtKB	Natural variant	347	347	.	.	.	ID=VAR_081197;Note=In GD1. I->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24577513;Dbxref=PMID:24577513	
P04062	UniProtKB	Natural variant	348	348	.	.	.	ID=VAR_003289;Note=In GD. A->V;Dbxref=dbSNP:rs78396650	
P04062	UniProtKB	Natural variant	350	350	.	.	.	ID=VAR_009044;Note=In perinatal lethal GD. H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10352942;Dbxref=dbSNP:rs78198234,PMID:10352942	
P04062	UniProtKB	Natural variant	351	351	.	.	.	ID=VAR_003290;Note=In GD%3B mild. W->C;Dbxref=dbSNP:rs121908304	
P04062	UniProtKB	Natural variant	351	351	.	.	.	ID=VAR_081198;Note=In GD1%3B loss of glucosylceramide catabolic process. W->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24022302;Dbxref=PMID:24022302	
P04062	UniProtKB	Natural variant	352	352	.	.	.	ID=VAR_003291;Note=In GD. Y->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8829663;Dbxref=PMID:8829663	
P04062	UniProtKB	Natural variant	354	354	.	.	.	ID=VAR_003292;Note=In GD. D->H;Dbxref=dbSNP:rs398123526	
P04062	UniProtKB	Natural variant	357	357	.	.	.	ID=VAR_003293;Note=In GD. A->D;Dbxref=dbSNP:rs78188205	
P04062	UniProtKB	Natural variant	362	362	.	.	.	ID=VAR_003294;Note=In GD%3B decreased glucosylceramidase activity%3B 6%25 of normal activity. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs76539814,PMID:16293621	
P04062	UniProtKB	Natural variant	363	363	.	.	.	ID=VAR_003295;Note=In GD%3B unknown pathological significance. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26528954;Dbxref=dbSNP:rs1178732315,PMID:26528954	
P04062	UniProtKB	Natural variant	364	364	.	.	.	ID=VAR_003296;Note=In GD2. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8294033;Dbxref=dbSNP:rs121908305,PMID:8294033	
P04062	UniProtKB	Natural variant	365	365	.	.	.	ID=VAR_003297;Note=In GD and GD1%3B mild%3B decreased glucosylceramidase activity%3B 42%25 of normal activity. E->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10796875,ECO:0000269|PubMed:16293621,ECO:0000269|PubMed:1864608,ECO:0000269|PubMed:24022302;Dbxref=dbSNP:rs2230288,PMID:10796875,PMID:16293621,PMID:1864608,PMID:24022302	
P04062	UniProtKB	Natural variant	368	368	.	.	.	ID=VAR_032411;Note=R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8294033;Dbxref=dbSNP:rs1064648,PMID:8294033	
P04062	UniProtKB	Natural variant	380	380	.	.	.	ID=VAR_009045;Note=In GD. A->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10796875,ECO:0000269|PubMed:9554454;Dbxref=dbSNP:rs781306264,PMID:10796875,PMID:9554454	
P04062	UniProtKB	Natural variant	381	381	.	.	.	ID=VAR_003298;Note=In GD2%3B loss of glucosylceramidase activity. C->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs121908306,PMID:16293621	
P04062	UniProtKB	Natural variant	388	388	.	.	.	ID=VAR_032207;Note=In GD%3B decreased glucosylceramidase activity%3B 12%25 of normal activity. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs1161552095,PMID:16293621	
P04062	UniProtKB	Natural variant	391	391	.	.	.	ID=VAR_010065;Note=In GD. V->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9153297;Dbxref=dbSNP:rs398123527,PMID:9153297	
P04062	UniProtKB	Natural variant	392	392	.	.	.	ID=VAR_010066;Note=In GD. R->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9650766;Dbxref=dbSNP:rs121908308,PMID:9650766	
P04062	UniProtKB	Natural variant	392	392	.	.	.	ID=VAR_032208;Note=In GD%3B decreased glucosylceramidase activity%3B 5%25 of normal activity. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs121908308,PMID:16293621	
P04062	UniProtKB	Natural variant	398	398	.	.	.	ID=VAR_003299;Note=In GD%3B mild. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8829663;Dbxref=dbSNP:rs74979486,PMID:8829663	
P04062	UniProtKB	Natural variant	400	400	.	.	.	ID=VAR_032412;Note=In GD. M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12204005;Dbxref=dbSNP:rs149487315,PMID:12204005	
P04062	UniProtKB	Natural variant	402	402	.	.	.	ID=VAR_032209;Note=In GD%3B decreased glucosylceramidase activity%3B 8%25 of normal activity%3B increases susceptibility to proteolytic degradation. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs76228122,PMID:16293621	
P04062	UniProtKB	Natural variant	403	403	.	.	.	ID=VAR_003300;Note=In GD%3B mild. S->T;Dbxref=dbSNP:rs121908307	
P04062	UniProtKB	Natural variant	405	405	.	.	.	ID=VAR_010067;Note=In GD. S->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9061570;Dbxref=PMID:9061570	
P04062	UniProtKB	Natural variant	405	405	.	.	.	ID=VAR_009046;Note=In GD. S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9554454;Dbxref=dbSNP:rs1392291885,PMID:9554454	
P04062	UniProtKB	Natural variant	405	405	.	.	.	ID=VAR_081199;Note=In GD1%3B loss of glucosylceramide catabolic process. S->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24022302;Dbxref=dbSNP:rs75528494,PMID:24022302	
P04062	UniProtKB	Natural variant	408	408	.	.	.	ID=VAR_003301;Note=In GD. T->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10796875,ECO:0000269|PubMed:14702039;Dbxref=dbSNP:rs75548401,PMID:10796875,PMID:14702039	
P04062	UniProtKB	Natural variant	409	409	.	.	.	ID=VAR_003302;Note=In GD1%3B mild%3B common mutation%3B associated with susceptibility to Parkinson disease%3B increased proteasomal degradation%3B decreased protein abundance%3B decreased glucosylceramide catabolic process%3B no effect on glucosylceramidase activity%3B alters interaction with saposin-C. N->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10206680,ECO:0000269|PubMed:10340647,ECO:0000269|PubMed:10447266,ECO:0000269|PubMed:10796875,ECO:0000269|PubMed:15605411,ECO:0000269|PubMed:15826241,ECO:0000269|PubMed:16293621,ECO:0000269|PubMed:18332251,ECO:0000269|PubMed:19286695,ECO:0000269|PubMed:19846850,ECO:0000269|PubMed:21098288,ECO:0000269|PubMed:24022302,ECO:0000269|PubMed:7627184,ECO:0000269|PubMed:8076951,ECO:0000269|PubMed:8937765,ECO:0000269|PubMed:9153297,ECO:0000269|Ref.14;Dbxref=dbSNP:rs76763715,PMID:10206680,PMID:10340647,PMID:10447266,PMID:10796875,PMID:15605411,PMID:15826241,PMID:16293621,PMID:18332251,PMID:19286695,PMID:19846850,PMID:21098288,PMID:24022302,PMID:7627184,PMID:8076951,PMID:8937765,PMID:9153297	
P04062	UniProtKB	Natural variant	410	410	.	.	.	ID=VAR_032210;Note=In GD%3B decreased glucosylceramidase activity%3B 15%25 of normal activity%3B increases susceptibility to proteolytic degradation. L->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs121908314,PMID:16293621	
P04062	UniProtKB	Natural variant	414	414	.	.	.	ID=VAR_010068;Note=In GD%3B mild. V->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9182788;Dbxref=dbSNP:rs398123528,PMID:9182788	
P04062	UniProtKB	Natural variant	416	416	.	.	.	ID=VAR_003303;Note=In GD%3B mild. G->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10447266,ECO:0000269|PubMed:10796875;Dbxref=dbSNP:rs121908311,PMID:10447266,PMID:10796875	
P04062	UniProtKB	Natural variant	417	417	.	.	.	ID=VAR_003304;Note=In GD. W->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8790604;Dbxref=dbSNP:rs1450426641,PMID:8790604	
P04062	UniProtKB	Natural variant	419	419	.	.	.	ID=VAR_003305;Note=In GD2%3B also found in a patient with Parkinson disease. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19286695;Dbxref=dbSNP:rs77284004,PMID:19286695	
P04062	UniProtKB	Natural variant	419	419	.	.	.	ID=VAR_032211;Note=In GD%3B decreased glucosylceramidase activity%3B 4%25 of normal activity. D->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=PMID:16293621	
P04062	UniProtKB	Natural variant	419	419	.	.	.	ID=VAR_003306;Note=In GD and GD1%3B loss of glucosylceramide catabolic process. D->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:24022302,ECO:0000269|PubMed:8790604;Dbxref=PMID:24022302,PMID:8790604	
P04062	UniProtKB	Natural variant	420	420	.	.	.	ID=VAR_081200;Note=In GD1%3B loss of glucosylceramide catabolic process. W->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24022302;Dbxref=PMID:24022302	
P04062	UniProtKB	Natural variant	421	421	.	.	.	ID=VAR_032212;Note=In GD%3B decreased glucosylceramidase activity%3B 22%25 of normal activity. N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=PMID:16293621	
P04062	UniProtKB	Natural variant	426	426	.	.	.	ID=VAR_010069;Note=In GD. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8937765;Dbxref=dbSNP:rs1057519357,dbSNP:rs994723035,PMID:8937765	
P04062	UniProtKB	Natural variant	428	428	.	.	.	ID=VAR_003307;Note=In GD2. G->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9554746;Dbxref=PMID:9554746	
P04062	UniProtKB	Natural variant	429	429	.	.	.	ID=VAR_032213;Note=In GD%3B decreased glucosylceramidase activity%3B 17%25 of normal activity. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=PMID:16293621	
P04062	UniProtKB	Natural variant	430	430	.	.	.	ID=VAR_003308;Note=In GD. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9554746;Dbxref=dbSNP:rs76910485,PMID:9554746	
P04062	UniProtKB	Natural variant	431	431	.	.	.	ID=VAR_003309;Note=In GD2. N->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9554746;Dbxref=dbSNP:rs77738682,PMID:9554746	
P04062	UniProtKB	Natural variant	432	432	.	.	.	ID=VAR_009047;Note=In GD. W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9554454;Dbxref=PMID:9554454	
P04062	UniProtKB	Natural variant	433	433	.	.	.	ID=VAR_003310;Note=In GD%3B severe%3B decreased glucosylceramidase activity%3B 12%25 of normal activity. V->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10796875,ECO:0000269|PubMed:16293621,ECO:0000269|PubMed:8937765;Dbxref=dbSNP:rs80356769,PMID:10796875,PMID:16293621,PMID:8937765	
P04062	UniProtKB	Natural variant	435	435	.	.	.	ID=VAR_003311;Note=In GD1%3B mild. N->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8889591;Dbxref=dbSNP:rs75385858,PMID:8889591	
P04062	UniProtKB	Natural variant	436	436	.	.	.	ID=VAR_032214;Note=In GD%3B decreased glucosylceramidase activity%3B 6%25 of normal activity%3B alters protein stability and increases susceptibility to proteolytic degradation. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs75243000,PMID:16293621	
P04062	UniProtKB	Natural variant	437	437	.	.	.	ID=VAR_009048;Note=In perinatal lethal GD. V->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10352942;Dbxref=dbSNP:rs121908310,PMID:10352942	
P04062	UniProtKB	Natural variant	437	437	.	.	.	ID=VAR_010070;Note=In GD3. V->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8780099;Dbxref=dbSNP:rs121908310,PMID:8780099	
P04062	UniProtKB	Natural variant	438	438	.	.	.	ID=VAR_003312;Note=In GD1 and GD2%3B decreased glucosylceramidase activity%3B 14%25 of normal activity%3B increases susceptibility to proteolytic degradation. D->N;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15605411,ECO:0000269|PubMed:16293621,ECO:0000269|PubMed:8112750;Dbxref=PMID:15605411,PMID:16293621,PMID:8112750	
P04062	UniProtKB	Natural variant	438	438	.	.	.	ID=VAR_032413;Note=In GD. D->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10796875;Dbxref=PMID:10796875	
P04062	UniProtKB	Natural variant	440	440	.	.	.	ID=VAR_010071;Note=In GD1. P->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10340647,ECO:0000269|PubMed:15605411;Dbxref=dbSNP:rs74598136,PMID:10340647,PMID:15605411	
P04062	UniProtKB	Natural variant	441	441	.	.	.	ID=VAR_032414;Note=In GD3. I->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11933202;Dbxref=PMID:11933202	
P04062	UniProtKB	Natural variant	441	441	.	.	.	ID=VAR_010072;Note=In GD%3B mild. I->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9182788;Dbxref=dbSNP:rs75564605,PMID:9182788	
P04062	UniProtKB	Natural variant	448	448	.	.	.	ID=VAR_003313;Note=In GD1 and GD3C%3B at homozygosity it causes GD3C%3B also found in a patient with Parkinson disease%3B gene conversion%3B very low glucosylceramidase activity%3B alters protein stability. D->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10360404,ECO:0000269|PubMed:10447266,ECO:0000269|PubMed:10796875,ECO:0000269|PubMed:11992489,ECO:0000269|PubMed:15605411,ECO:0000269|PubMed:16293621,ECO:0000269|PubMed:19286695,ECO:0000269|PubMed:7475546,ECO:0000269|PubMed:7627184,ECO:0000269|PubMed:9040001,ECO:0000269|PubMed:9061570;Dbxref=dbSNP:rs1064651,PMID:10360404,PMID:10447266,PMID:10796875,PMID:11992489,PMID:15605411,PMID:16293621,PMID:19286695,PMID:7475546,PMID:7627184,PMID:9040001,PMID:9061570	
P04062	UniProtKB	Natural variant	448	448	.	.	.	ID=VAR_003314;Note=In GD%3B severe%3B very low activity%3B alters protein stability. D->V;Dbxref=dbSNP:rs77369218	
P04062	UniProtKB	Natural variant	450	450	.	.	.	ID=VAR_010073;Note=In GD. F->I	
P04062	UniProtKB	Natural variant	451	451	.	.	.	ID=VAR_003315;Note=In GD. Y->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9554746;Dbxref=PMID:9554746	
P04062	UniProtKB	Natural variant	452	452	.	.	.	ID=VAR_010074;Note=In GD. K->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9061570;Dbxref=PMID:9061570	
P04062	UniProtKB	Natural variant	454	454	.	.	.	ID=VAR_003316;Note=In GD2. P->R;Dbxref=dbSNP:rs121908295	
P04062	UniProtKB	Natural variant	455	455	.	.	.	ID=VAR_032215;Note=In GD%3B loss of glucosylceramidase activity%3B increases susceptibility to proteolytic degradation. M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=PMID:16293621	
P04062	UniProtKB	Natural variant	456	456	.	.	.	ID=VAR_003317;Note=In GD. F->V	
P04062	UniProtKB	Natural variant	457	457	.	.	.	ID=VAR_003318;Note=In GD. Y->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15605411,ECO:0000269|PubMed:8076951;Dbxref=dbSNP:rs74752878,PMID:15605411,PMID:8076951	
P04062	UniProtKB	Natural variant	460	460	.	.	.	ID=VAR_032415;Note=In GD1%3B associated with R-490%3B loss of glucosylceramidase activity. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15605411;Dbxref=PMID:15605411	
P04062	UniProtKB	Natural variant	464	464	.	.	.	ID=VAR_003319;Note=In GD%3B severe. K->E	
P04062	UniProtKB	Natural variant	482	482	.	.	.	ID=VAR_063067;Note=In a patient with Parkinson disease. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19286695;Dbxref=dbSNP:rs75671029,PMID:19286695	
P04062	UniProtKB	Natural variant	483	483	.	.	.	ID=VAR_003321;Note=In GD1 and GD2%3B common mutation%3B associated with susceptibility to Parkinson disease%3B gene conversion%3B alters protein stability%3B increased proteasomal degradation%3B decreased protein abundance%3B very low glucosylceramide catabolic process%3B no effect on glucosylceramidase activity. L->P;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10360404,ECO:0000269|PubMed:10447266,ECO:0000269|PubMed:10796875,ECO:0000269|PubMed:15605411,ECO:0000269|PubMed:16293621,ECO:0000269|PubMed:19286695,ECO:0000269|PubMed:21098288,ECO:0000269|PubMed:7627184,ECO:0000269|PubMed:8937765,ECO:0000269|PubMed:9061570,ECO:0000269|PubMed:9217217,ECO:0000269|PubMed:9851895;Dbxref=dbSNP:rs421016,PMID:10360404,PMID:10447266,PMID:10796875,PMID:15605411,PMID:16293621,PMID:19286695,PMID:21098288,PMID:7627184,PMID:8937765,PMID:9061570,PMID:9217217,PMID:9851895	
P04062	UniProtKB	Natural variant	483	483	.	.	.	ID=VAR_003320;Note=In GD%3B severe. L->R;Dbxref=dbSNP:rs421016	
P04062	UniProtKB	Natural variant	485	485	.	.	.	ID=VAR_003322;Note=In GD. A->P	
P04062	UniProtKB	Natural variant	486	486	.	.	.	ID=VAR_081201;Note=In GD1. V->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22658918;Dbxref=PMID:22658918	
P04062	UniProtKB	Natural variant	490	490	.	.	.	ID=VAR_032416;Note=In GD1%3B associated with D-460. H->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12204005,ECO:0000269|PubMed:15605411;Dbxref=dbSNP:rs76071730,PMID:12204005,PMID:15605411	
P04062	UniProtKB	Natural variant	495	495	.	.	.	ID=VAR_003323;Note=In GD%3B gene conversion. A->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19286695;Dbxref=dbSNP:rs368060,PMID:19286695	
P04062	UniProtKB	Natural variant	497	497	.	.	.	ID=VAR_063068;Note=V->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19286695;Dbxref=PMID:19286695	
P04062	UniProtKB	Natural variant	500	500	.	.	.	ID=VAR_032216;Note=In GD%3B decreased glucosylceramidase activity%3B 10%25 of normal activity%3B increases susceptibility to proteolytic degradation. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=dbSNP:rs1362103320,PMID:16293621	
P04062	UniProtKB	Natural variant	501	501	.	.	.	ID=VAR_009049;Note=In GD2. N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9279145;Dbxref=PMID:9279145	
P04062	UniProtKB	Natural variant	502	502	.	.	.	ID=VAR_003324;Note=In GD%3B also found in patients with Parkinson disease%3B no effect on protein abundance%3B decreased glucosylceramidase activity%3B 37%25 of normal activity. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10796875,ECO:0000269|PubMed:16293621,ECO:0000269|PubMed:19286695,ECO:0000269|PubMed:1972019,ECO:0000269|PubMed:7627184;Dbxref=dbSNP:rs80356771,PMID:10796875,PMID:16293621,PMID:19286695,PMID:1972019,PMID:7627184	
P04062	UniProtKB	Natural variant	502	502	.	.	.	ID=VAR_032217;Note=In GD%3B loss of glucosylceramidase activity%3B increases susceptibility to proteolytic degradation. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=PMID:16293621	
P04062	UniProtKB	Natural variant	509	509	.	.	.	ID=VAR_003325;Note=L->P	
P04062	UniProtKB	Natural variant	513	513	.	.	.	ID=VAR_009050;Note=In GD2. D->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9637431;Dbxref=PMID:9637431	
P04062	UniProtKB	Natural variant	517	517	.	.	.	ID=VAR_003326;Note=In GD. G->S;Dbxref=dbSNP:rs121908301	
P04062	UniProtKB	Natural variant	530	530	.	.	.	ID=VAR_010075;Note=In GD3. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8780099;Dbxref=dbSNP:rs78016673,PMID:8780099	
P04062	UniProtKB	Natural variant	535	535	.	.	.	ID=VAR_003327;Note=In GD%3B mild. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9061570;Dbxref=dbSNP:rs747506979,PMID:9061570	
P04062	UniProtKB	Natural variant	535	535	.	.	.	ID=VAR_003328;Note=In GD%3B mild. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7916532;Dbxref=dbSNP:rs75822236,PMID:7916532	
P04062	UniProtKB	Mutagenesis	43	43	.	.	.	Note=Loss of glucosylceramidase activity. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=PMID:16293621	
P04062	UniProtKB	Mutagenesis	57	57	.	.	.	Note=Loss of glucosylceramidase activity. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=PMID:16293621	
P04062	UniProtKB	Mutagenesis	62	62	.	.	.	Note=Loss of glucosylceramidase activity. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16293621;Dbxref=PMID:16293621	
P04062	UniProtKB	Mutagenesis	379	379	.	.	.	Note=1000-fold decreases of glucosylceramidase activity. E->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:7908905;Dbxref=PMID:7908905	
P04062	UniProtKB	Sequence conflict	176	176	.	.	.	Note=D->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P04062	UniProtKB	Sequence conflict	227	227	.	.	.	Note=N->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P04062	UniProtKB	Sequence conflict	470	470	.	.	.	Note=S->I;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P04062	UniProtKB	Sequence conflict	534	534	.	.	.	Note=R->H;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P04062	UniProtKB	Beta strand	49	52	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	54	57	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	75	82	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	88	94	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	96	98	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	103	116	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	119	123	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Helix	126	133	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Helix	137	148	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Turn	150	153	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	157	163	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	166	170	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	177	179	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1OGS	
P04062	UniProtKB	Helix	190	193	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Helix	196	206	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	212	218	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Helix	222	224	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	225	227	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2J25	
P04062	UniProtKB	Beta strand	229	233	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	235	238	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Helix	243	261	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	267	271	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Helix	275	279	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	284	286	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3GXF	
P04062	UniProtKB	Helix	292	301	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Helix	303	308	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Turn	311	314	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	315	323	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Helix	324	326	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Helix	329	335	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Helix	338	341	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	346	352	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Helix	354	356	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3GXI	
P04062	UniProtKB	Helix	359	369	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	373	381	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	386	388	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2J25	
P04062	UniProtKB	Helix	396	411	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	414	424	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	426	428	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3KEH	
P04062	UniProtKB	Beta strand	440	444	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Helix	445	447	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	449	452	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Helix	454	463	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	471	479	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	482	489	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	495	501	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	503	505	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	507	513	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Turn	514	516	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	517	523	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
P04062	UniProtKB	Beta strand	527	533	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2NT0	
